Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros. The terms of the agreement were not disclosed at this time. The transaction is […]
CAMBRIDGE, Mass. — Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations. Progenika’s blood group genotyping microarray, which simultaneously […]
MUKILTEO, Wash. — CombiMatrix Corporation (Nasdaq:CBMX – News) announced today that Mr. Chris Emery and Dr. Lony Lim have joined its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), as Chief Operating Officer and Vice President of Operations, respectively. The tandem will use their extensive laboratory diagnostics services expertise to help implement the company’s strategic initiatives […]
Residency Training Program Incorporates Personal Genomics into Physician Education BOSTON & FOSTER CITY, Calif. — Beth Israel Deaconess Medical Center and Navigenics, Inc., a leading personal genomics company, today announced a collaboration to make personalized genomics available to doctors in training. Beth Israel Deaconess Medical Center (BIDMC) has launched the Personalized Genomics and Next Generation […]
MADISON, Wis. — Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has obtained a worldwide license from Hologic Inc. for that company’s Invader, Invader plus and real-time Invader detection chemistries for the field of colorectal cancer screening. Financial terms of the license agreement were not disclosed. The Invader chemistry, which is being commercialized by […]
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio SAVANNAH, Ga. — Health Discovery Corporation (OTCBB: HDVY) is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued […]
Dr. Leroy Hood-Led Venture Secures $30 Million Series A Financing From InterWest Partners, Wellcome Trust and dievini SEATTLE, WA — Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics […]
LONDON–Smiths Detection today announces the award of a $2.2m, two-year grant from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop a test for multiple types of influenza. The test will run on Smiths Detection’s Clinical Bio-Seeq instrument, designed to be used at Point of […]
Respiratory Virus Testing and Information Website – New Website Provides Doctors and Patients Timely Information on Avoiding and Detecting Flu and Other Respiratory Viruses AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, has launched a new website: www.xTAGRVP.com. The website was created as a resource for physicians and patients seeking […]
LONDON–Smiths Detection today announces the award of a $1m, two-year grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a rapid test for eight micro-organisms that commonly cause burn/wound infections leading to septicemia (blood-poisoning). The test will run on Smiths Detection’s Clinical Bio-Seeq System, designed to be used at Point of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
